Docket Room.
HB 1667·MS·house

Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.

FailedFiled Jan 19, 2026
Sponsor: Tullos
Latest Action

(H) Died In Committee

Feb 3, 2026

Email me when HB 1667 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 1667. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would force health benefit plans and prescription‑drug programs that receive manufacturer copay assistance to count that assistance against a patient’s drug cost, deductible or annual out‑of‑pocket maximum. It also updates insurance code sections dealing with contract language and cash‑discount cards. The measure failed in committee and did not become law.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 1667

3 free questions a day, no account

History

  1. Died In Committee
  2. Referred To State Affairs

Sponsors

  • Tullos · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 1667 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 1667 free

Or ask your AI assistant about HB 1667 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice